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Why was the cohort set up?
Population ageing is affecting low- and middle-income
countries, with absolute and relative numbers of older
adults increasing quickly across the globe. This demo-
graphic transition is accompanied by a health transition,
driven by changing habits and lifestyles, where non-com-
municable diseases are becoming the major cause of mor-
bidity. Dementia is strongly associated with age and is one
of the main contributors to dependence and disability. It
has been estimated that there are nearly 47 million people
currently living with dementia, most of whom live in low-
and middle-income countries (LMICs).
The title of the 10/66 Dementia Research Group
(DRG) reflects the fact that, when the group was formed
in 1998, less than 10% of population-based research on
dementia had been carried out in developing countries al-
though two-thirds of those affected lived in those set-
tings.1 The 10/66 DRG research programme was
developed to address this inequity, quantifying dementia
prevalence, incidence and impact across Latin American
countries, China and India, using a validated and com-
mon methodology. However, given that this was a popu-
lation cohort, the scope of the research was much broader
than this—entailing a comprehensive enquiry into health
(common and burdensome chronic diseases, disability
and health service utilization), and social aspects of age-
ing (socioeconomic status, social protection, needs for
care and care arrangements).
Fundamental methodological issues, in particular the
development, calibration and validation of culture- and
education-fair dementia diagnosis, and care arrangements
for care-dependent older people, were addressed in pilot
investigations in 26 centres from 16 low- and middle-in-
come countries in Latin America and the Caribbean,
Africa, India, Russia, China and South East Asia (1999–
2001).2–5 The protocols for the 10/66 DRG baseline
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surveys and incidence phase surveys have already been
described in detail in a previous publication.6 The purpose
of this paper is to describe in more detail the resources cre-
ated through these completed surveys, together with find-
ings from the research completed to date and further plans
for development of this resource.
Where is it located, who set it up and how
has it been funded?
The 10/66 DRG is coordinated from London, within the
Centre for Global Mental Health at King’s College
London, with a network of centres each led by a local
principal investigator. The 10/66 DRG’s research has
been funded by the Wellcome Trust Health Consequences
of Population Change Programme (GR066133—
Prevalence phase in Cuba and Brazil; GR08002—
Incidence phase in Peru, Mexico, Cuba, Dominican
Republic, Venezuela and China), World Health
Organization (India, Dominican Republic and China),
the US Alzheimer’s Association (IIRG–04–1286—Peru
and Mexico), FONACIT/ CDCH/ UCV (Venezuela), and
Puerto Rico Legislature (data collection in Puerto Rico)
and Pfizer Co., USA (blood sample collection in Puerto
Rico). The new cohort is funded by a European Research
Council Advanced Grant (340755). The Rockefeller
Foundation supported our dissemination strategy meeting
at their Bellagio Centre. Alzheimer Disease International
(ADI) has provided support for networking and
infrastructure.
Who is in the cohort?
The 10/66 cohort is a population cohort comprising in
principle all older residents aged 65 years and over, living
in 11 geographically defined urban and rural catchment
area sites in eight low- and middle-income countries. The
selection of catchment areas for the baseline phase of the
survey was purposive, based upon their accessibility, their
use in the past as field sites for community or population
research and the existence of or potential for development
of good relationships between the local research groups
and community stakeholders. Urban sites were selected to
comprise mixed or mainly lower socioeconomic status
households; exclusively high-income or professional dis-
tricts were excluded. Urban sites were located in Cuba
(one catchment area comprising sites is Havana and
Matanzas), Dominican Republic (Santo Domingo),
Puerto Rico (Bayamon), Venezuela (Caracas), Peru
(Lima), Mexico (Mexico City), China (Xicheng, Beijing
province) and India (Chennai). Rural sites, selected to be
remote from major population centres, with low-density
population and with agriculture and related trades as the
main local employment, were located in Peru (Canete
Province), Mexico (Morelos State) and China (Daxing,
Beijing Province). The centre and site characteristics are
summarized in Figure 1. The baseline phase was con-
ducted for all centres between 2004 and 2006, with the
exception of Puerto Rico where baseline data were col-
lected between 2007 and 2010 (Figure 2). Mapping of the
catchment areas was carried out within specified bounda-
ries, and households were allocated household identifica-
tion numbers. Enumeration was carried out by
door-knocking all households in the catchment area to
identify potentially eligible participants (those aged 65
years or over on a census date) who were then allocated
participant identification numbers. These are linked to
names and addresses in secure databases held in London.
Participants’ ages were confirmed during the interview.
Information about the age and sex of all other co-
residents was also recorded. After verifying eligibility,
written consent was obtained from participants or next of
kin if the individual lacked capacity. Oral consent, wit-
nessed in writing by someone literate, was taken from il-
literate participants. An overall sample of 2000 per
country would allow estimation of a typical dementia
prevalence of 4.5% with a precision of 6 0.9%, and rural
and urban samples of 1000 each would allow estimation
of the same prevalence with a precision of 6 1.2%.
A sample size of around 2000 individuals for each coun-
try was achieved and the response rate was excellent in
most catchment areas, with a range of 72 % to 98% by
site, and an average across sites of 86% (Table 1).
The completed cohort resource
The cohort at baseline, with respect to vital status ascer-
tained through to March 2014, comprised 15 901 partici-
pants at risk (Table 1; and Supplementary Table 1,
available as Supplementary data at IJE online). The me-
dian follow-up period ranged from 2.8 to 5.0 years by site,
with a total of 53 872 person-years of observation. The
vital status of 13 936 participants (87.7%) was deter-
mined, with 2602 deaths occurring during the follow-up
period, for which 2436 verbal autopsy interviews were
completed. The proportion deceased at follow-up was
higher in China, Dominican Republic and Cuba than in
other countries (in part a function of the longer follow-up
interval in those sites). With respect to the incidence of de-
mentia (further excluding India, where dementia-free par-
ticipants were not followed up), 14 896 participants were
interviewed at baseline, 13 483 free of dementia; 9322 (69.
1%) were re-interviewed, contributing 42 698 person-years
of follow-up.
2 International Journal of Epidemiology, 2016, Vol. 0, No. 0
 at K
ing's College London - Journals D
ept on M
ay 23, 2016
http://ije.oxfordjournals.org/
D
ow
nloaded from
 
How often have they been followed up?
Participants of the baseline assessment were traced and fol-
lowed up between 2007 and 2010 in the China, India
(mortality only), Cuba, Dominican Republic, Mexico,
Peru and Venezuela sites, and between 2012 and 2013 in
Puerto Rico. In India, all those with mild cognitive impair-
ment, ‘cognitive impairment no dementia’ (CIND) or de-
mentia at baseline completed the full incidence phase
protocol, to determine the predictive validity of baseline
dementia diagnosis.7 A mortality sweep was carried out on
the full baseline cohort to determine vital status, date of
death of those deceased and a verbal autopsy on those
deceased.8
Subsequent to the baseline and incidence waves, the 10/
66 INDEP sub-study has been completed,9 a nested study
of households in Peru, Mexico and China, characteriszd as
‘incident care’, ‘chronic care’ or ‘no care’, depending upon
the needs for care of older residents. This focuses on the
economic and social functioning of the household as a
whole. A third full wave of assessment using an extended
form of the basic 10/66 survey has recently been planned
and funded for Cuba, Dominican Republic, Puerto Rico,
Mexico, Peru, Venezuela and China, which will take place
approximately 10 years on from the original baseline sur-
veys (2015–16).This will be a new prevalence sweep, with
renewed -door-knocking of the original catchment areas to
Figure 1 Distribution of the 10/66 centres. Countries in purple contain both rural and urban centres, whereas countries in orange only have urban
centres. The black dots represent the catchment areas within each country. The centres are the following: China (Beijing and Daxing), Cuba (Havana/
Matanzas), Dominican Republic (Santo Domingo), India (Chennai), Mexico (Mexico City and Morelos/Hidalgo), Peru (Lima and Canete), Puerto Rico
(San Juan) and Venezuela (Caracas).
Cuba
Domican Republic
Peru urban
Peru rural
Venezuela
Mexico urban
Mexico rural
China urban
China rural
India
Puerto Rico
2015 2016 2017
1st wave 2nd wave 3rd wave
2009 2010 2011 2012 2013 20142003 2004 2005 2006
n-933n = 1000
2007 2008
n = 1002 n = 1002
487n = 1005
n = 2009
n = 1160 n = 989
n = 2813 n = 2653
3rd wave + 2nd cohort
n = 2011 n = 1706
n = 1245n = 1381
n = 507n = 552
n = 1965
n = 1567
n = 1697
n = 911n = 1003
Figure 2 Cohort diagram of the baseline and follow-up surveys; 2nd wave numbers refer to number of people with a determined vital status.
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generate a new representative prevalence sample of all
those aged 65 years and over, including those that have
aged to 65 years or over since the first prevalence wave,
and in-migrants. Participants of the original baseline sur-
vey will be traced and have their vital status ascertained,
and be re-interviewed where possible even if migrated out
of the area.
What has been measured?
The same cross-culturally validated assessment was carried
out across each centre, during the baseline and follow-up
phase of the study. All participants underwent a compre-
hensive interview, including a structured interview, a phys-
ical examination and an informant interview. Key
informants were selected by interviewers on the basis of
who knew the old person best and could give the clearest
and most detailed account of their current circumstances.
Co-residents and family members were prioritized unless
others were clearly better qualified. The main criterion for
selection in case of several co-resident family members was
time spent with the older person. In cases where the older
person needed care, then the main caregiver was selected.
However, if the main caregiver was paid, the main organ-
izational caregiver was selected instead.
Each full assessment, which lasted between 2 and 3 h,
was translated, back-translated and adapted as necessary
into the different languages for each centre (Table 2).
Socio-demographics
Information on age, sex, marital status, level of education
(none; some, but did not complete primary; completed
primary; completed secondary; completed tertiary or fur-
ther education), household assets and household compos-
ition was assessed by a standard socio-demographic
questionnaire.
Health
For some conditions, health status was assessed using self-
reported diagnoses, in response to the question ‘has a doc-
tor ever told you that you suffered from’: stroke, diabetes,
hypertension, heart disease (and hyperlipidaemia, at fol-
low-up only), TB, malaria or cysticercosis, and treatments
for these conditions. Directly assessed diagnoses included:
(i) Dementia, ascertained according to the cross-culturally
validated 10/66 dementia diagnosis algorithm3 and the
DSM-IV dementia criterion10 after cognitive testing, clin-
ical and informant interview; (ii) Depression according to
ICD-10 criteria and EURO-D scale scores, and syndromal
levels of anxiety and psychosis ascertained using the
structured Geriatric Mental State clinical interview
(GMS);11–13 (iii) Hypertension according to European
Society of Hypertension criteria (systolic blood pressure
>¼140 mmHg and/or diastolic blood pressure
>¼95 mmHg, and/or a positive answer to the question
‘have you ever been told by a doctor that you have hyper-
tension?’); (iv) Chronic Obstructive Pulmonary Disease
(COPD) diagnosed in those who responded ‘yes’ to the
question ‘do you usually cough up phlegm from your chest
first thing in the morning?’ and whose answer to the ques-
tion ‘for how many months of the year does this usually
happen?’ was 3 months or more.
Self-rated overall health and physical impairments
(including eyesight problems; stomach or intestine prob-
lems; arthritis or rheumatism; heart problems; hearing dif-
ficulties or deafness etc.) were also assessed. Impairments
were rated as present if they interfered with activities ‘a lit-
tle’ or ‘a lot’, as opposed to ‘not at all’.14 Women’s repro-
ductive history (menarche, menopause and parity) was
also assessed. The informant rated the presence and sever-
ity of any behavioural and psychological symptoms
(Neuropsychiatric Inventory Questionnaire -NPI-Q).15
Finally, a physical examination was carried out com-
prising pulse and blood pressure, height, leg length, skull,
arm, waist and hip circumference and a structured neuro-
logical examination (NEUROEX).6 At follow-up only,
weight and calf circumference were also assessed.
Impacts of health
1. Disability. Disability was measured using the 12-item
World Health Organization Disability Assessment
Schedule version 2.0 (WHODAS 2.0). The WHODAS
2.0 has high internal consistency, moderate to
good test-retest reliability and good concurrent validity
in many different chronic disease clinical popula-
tions.16–18
2. Dependence. The interviewer administered open-ended
questions to the key informant, to ascertain needs for
care. The interviewer then coded whether the partici-
pant required no care, care some of the time or care
much of the time. This coding was based upon the
interviewer’s perception of needs for care, independ-
ently of whether these were routinely met.
Conditionally upon the presence of needs for care, we
further assessed: (i) Practical impact—contact time be-
tween caregiver and cared-for person19 and time spent
by the caregiver in the past 24 h in specific caregiving
activities;20 (ii) Caregiver perceived strain—the Zarit
Burden Interview (ZBI)21,22 with 22 items that assess
the caregiver’s appraisal of the impact their involve-
ment has had on their lives.
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Table 2. Measurements in the different waves of studies. WHODAS (World Health Organization Disability Assessment
Schedule), DEMQOL (Dementia Quality Of Life Questionnaire), CSI’D’ (Community Screening Instrument for Dementia), HAS
(History and Aetiology Schedule), NPI (Neuropsychiatric Inventory), GMS (Geriatric Mental State Examination)
Baseline Follow-up 3rd wave/refreshment
cohort
Household assessment x x x
Age ascertainment x x
Household information x x x
Number of assets x x x
Participant interview x x x
Early-life events x x x
Current circumstances x x x
Social network x x x
Socioeconomic status x x x
Health (including pain and impairments) x x x
Disability (WHODAS-II) and dependence x x x
Reproductive health x x x
Behaviour and lifestyles x x x
Use of health services x x x
Quality of life (DEMQOL) x x
Cognitive functioning
CSI’D’ x x x
10-word list-learning test x x x
Mental health (GMS – version B3) x x x
Clinical examination
Neurological assessment (NEUROEX) x x x
Physical assessment (anthropometry, pulse/blood pressure) x x x
Stroke assessment x
Advanced frailty assessment x
Biological assessments
Haematological tests, full blood count
(haemoglobin, haematocrit, differential, MCV, MCH, MCHC)
x x x
(some centres) (some centres)
Biochemical tests
(fasting glucose, fasting total cholesterol and sub-fractions,
triglyceride, albumin, total protein)
x x x
(some centres) (some centres)
Genotyping (ApoE) x x x
(some centres) (some centres)
Metabolic syndrome according to NCEP-ATP III criteria x x x
(some centres) (some centres)
Age-related decline biomarkers
(cytokines, telomeres, CRP, testosterone, SHBG)
x
(nested-cohort)
a) Informant interview
Background information on informant x x x
Caregiver questionnaire x x x
CSI’D’ informant section x x x
HAS-D x x x
Behavioural and Psychological Symptoms of Dementia (NPI) x x x
Participants background infoa x x x
DEMQOL x x
Verbal autopsy x x
aAdministered when the participant is too demented or otherwise unable to answer the questions reliably.
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3. Health service utilization was assessed using the Client
Service Receipt Inventory,23 a comprehensive assess-
ment of direct and indirect economic costs for mental
health services, adapted for use in the developing
world.24 Help-seeking, specifically for symptoms and
signs of dementia, was assessed at follow-up only.
Risk exposures
Specific dementia risk factors (e.g. head injury with loss of
consciousness, family history of dementia) and broader life-
style and cardiovascular risk factors including alcohol use
(volume and frequency currently and before the age of 60),
lifetime smoking (including pack-year calculation) and diet
and exercise levels now and in earlier life, were also assessed.
Biological samples
Fasting blood samples were collected in a subset of seven
Latin American sites (Cuba, Dominican Republic,
Venezuela, Puerto Rico, urban Peru, and urban and rural
Mexico), for which we are also able to report the preva-
lence of undiagnosed diabetes and the extent of control
among diagnosed cases. We collected fluoride oxalate,
EDTA and clot samples. Haematological and biochemical
analyses were carried out in local laboratories. DNA was
extracted to create a resource for genotyping. The range of
assays carried out varied among sites, depending on feasi-
bility and funding (see Table 2; and Supplementary
Table2, available as Supplementary data at IJE online).
Overall, 9178 blood samples were collected. By site, the
numbers and proportions providing samples were: Cuba
(2355, 80.4% of those participating in the survey),
Dominican Republic (1483, 73.8%), Puerto Rico (1584,
78.8%), Venezuela (1284, 65.3%), urban Peru (755,
54.7%), urban Mexico (822, 82.0%) and rural Mexico
(895, 89.5%). There were few differences in baseline char-
acteristics of those who did and did not provide samples
(Supplementary Table 3, available as Supplementary data at
IJE online), and those differences were generally of small ef-
fect, other than in the urban Peru site where the more afflu-
ent and better educated, but also those with more physical
impairments, were more likely to give blood samples.
The new third-wave prevalence survey will include an
extended assessment of health status, including spirometry,
body mass index (BMI), visual acuity, grip strength and
hearing impairment. Moreover, a nested cohort of 300 in-
dividuals (150 with a high risk of incident dependence and
150 without) will be identified and extensive laboratory
testing of frailty biomarkers carried out. This sub-group
will be followed up 18 months later to re-assess vital
status, needs for care, disability, cognitive function and sig-
nificant health life events in the intervening period.
What has it found? Key findings and
publications
Evidence on the construct and predictive validity of key
measures has been further strengthened. Norms for the cog-
nitive tests indicate effects of age and education, and a mod-
est effect of culture upon the cognitive tests (10-word
delayed recall and CSI-D COGSCORE) that form the core
of our 10/66 dementia diagnosis.25 Our confidence in the
validity of the 10/66 dementia diagnosis has been bolstered
by the demonstration, in Cuba, that it agreed better with
Cuban clinician diagnoses than did the DSM-IV compu-
terzsed algorithm, which missed many recent-onset and
mild cases.10 Across the cohort, levels of disability were
similar for 10/66 dementia cases regardless of whether they
were confirmed as cases by the DSM-IV dementia algo-
rithm.26 Crucially, in urban India where the disparity be-
tween the prevalence of 10/66 dementia and DSM-IV
dementia was greatest, those with 10/66 dementia had a
markedly elevated mortality rate, and survivors showed
clear evidence of clinical progression and increased needs
for care. Only one ‘case’ had unambiguously improved.
Cognitive function had deteriorated and disability increased
to a much greater extent than among those with CIND.
Hence, the strong predictive validity of the 10/66 dementia
diagnosis is consistent with a lack of sensitivity of the DSM-
IV criteria to mild-to-moderate cases, which may underesti-
mate prevalence in less developed regions. Regarding the
WHODAS 2.0 disability assessment scale, in the 10/66
DRG population-based survey samples strong internal con-
sistency and high factor loadings for the one-factor solution
supported unidimensionality, and the WHODAS 2.0 was
found to be a ‘strong’ Mokken scale in all sites.27
Morbidity in the baseline surveys of the cohort has been
described in detail, with publications on the prevalence of
dementia,26 mild cognitive impairment,28 mental dis-
order,29–32 sleep disorder,33 hypertension,34 stroke,35 an-
aemia,36 head injury37 and dependence38 (Table 3).
Prevalence of most chronic disorders, including dementia, is
similar to that in high-income countries for urban settings in
Latin America and China, and somewhat lower in rural set-
tings and in India. Detailed country reports delineate the im-
pact of population ageing and the epidemiological
transition on patterns of chronic disease morbidity and
needs for care in Cuba,39 Dominican Republic40 and
China.41 The independent impact of different chronic dis-
eases and frailty42 on disability,43 dependence,38 co-resident
psychological morbidity,44 service utilization24 and costs,45
indicating a predominant contribution of disorders of the
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brain and mind (dementia, stroke and depression) to disabil-
ity, dependence and costs, but an inverse association be-
tween dementia and healthcare service utilization.
The incidence of 10/66 dementia ranged from 18.2 to
30.4 per 1000 person-years, similar or higher than the inci-
dence of dementia reported for high-income countries.
Incidence of 10/66 dementia was 1.4–2.7 times higher than
that for DSM-IV dementia (15.7 and 9.9 per 1000 person-
years, respectively).46 Mortality hazards ratios for dementia
ranged from 1.56 to 5.69 by site.46 Education [hazard ratio
(HR): 0.89, 95% confidence interval (CI): 0.81–0.97], and
male sex (0.72, 0.61–0.84) were inversely associated, and
older age [risk ratio (RR) per 5-year band 1.67, 1.56–1.79]
were all associated with incident dementia. Literacy, motor
sequencing and verbal fluency all protected against demen-
tia onset, independent of education, providing support for
the cognitive reserve hypothesis.
Crude mortality rates varied from 27.3 to 70.0/1000
person-years, a 3-fold variation persisting after standard-
ization for demographic and economic factors.47
A full list of findings and publications can be found on
the study website [http://www.alz.co.uk/1066/1066_publi
cations.php] and in Supplementary Table 4 (available as
Supplementary data at IJE online).
What are the main strengths and
weaknesses?
One of the main strengths of this study was the use of a
one-phase design to estimate the prevalence, incidence, de-
terminants and consequences of a comprehensive range of
chronic conditions, with a particularly robust dementia
assessment procedure specifically developed and validated
for use in LMIC. The same standardized protocol, which
included validated measurements and diagnostic algo-
rithms, was used in each site, permitting comparison of es-
timates across diverse settings and aiding the interpretation
of observed variations. The relatively large sample size also
allows quite precise estimations of effect sizes, in particular
with meta-analysed pooled estimates. Response rates were
also high, and the number of missing values relatively low.
Although the use of catchment areas increased the response
rates, this could have affected the generalizability of the
findings beyond the specific study sites.
Can I get hold of the data? Where can I find
out more?
The 10/66 cohort is an open-access database, and we
would encourage external investigators to consider apply-
ing to use the data for secondary analyses, in order to
maximize the scientific output from the data. All the infor-
mation on how to access the 10/66 public data archive,
with a list of current proposals and papers currently under
preparation, can be found on our website: [www.alz.co.
uk/1066/].
Supplementary Data
Supplementary data are available at IJE online.
Funding
This work was supported by the Wellcome Trust (GR066133/
GR080002), the European Research Council (340755), US
Table 3.Morbidity at baseline across sites, n (%)
Cuba Dominican
Republic
Puerto
Rico
Peru
urban
Peru
rural
Venezuela Mexico
urban
Mexico
rural
China
urban
China
rural
India
urban
Dementiaa 292 (10.4) 235 (11.7) 233 (11.7) 129 (9.34) 36 (6.5) 140 (7.1) 86 (8.6) 85 (8.5) 81 (7.0) 556 (5.6) 75 (7.5)
Mild cognitive
impairmentb
42 (1.5) 26 (1.3) 68 (3.4) 36 (2.6) 18 (3.3) 22 (1.1) 27 (2.7) 32 (3.2) 5 (0.4) 12 (1.2) 33 (3.3)
Strokec 216 (7.7) 175 (8.7) 168 (8.4) 112 (8.2) 20 (3.6) 135 (7.0) 67 (6.7) 74 (7.4) 109 (9.4) 18 (1.8) 20 (2.0)
Hypertensiond 1624 (57.9) 968 (48.6) 518 (32.1) 209 (15.2) 37 (6.7) 714 (46.5) 423 (42.2) 371 (37.2) 489 (42.4) 557 (55.6) 608 (60.7)
Alcohol problems
Early life 212 (7.6) 605 (30.4) 132 (6.6) 18 (1.3) 17 (3.1) 88 (7.4) 80 (8.1) 112 (11.3) 26 (2.2) 73 (7.3) 4 (0.4)
Current 103 (3.7) 234 (11.7) 28 (1.4) 3 (0.2) 5 (0.9) 17 (1.5) 9 (0.9) 11 (1.1) 17 (1.5) 42 (4.2) 1 (0.1)
Needs for Caref 157 (6.4) 143 (7.1) 182 (9.1) 75 (5.4) 10 (1.8) 98 (5.0) 56 (5.6) 30 (3.0) 119 (10.3) 30 (3.0) 14 (1.4)
Depressiong 142 (5.1) 278 (13.8) 47 (2.3) 87 (6.3) 16 (2.9) 107 (5.5) 47 (4.7) 45 (4.5) 3 (0.3) 7 (0.7) 39 (3.9)
a10/66 education-adjusted dementia diagnosis.
bPetersen criteria amnesic MCI.
cSelf reported stroke.
dMeeting ISH hypertension criteria ( 14 mmHg systolic and/or  90 mmHg diastolic).
eHazardous drinker.
fNeeding much care most of the time.
gICD-10 Depression.
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